Globus Medical (GMED) – StreetInsider.com Reports
-
Analyst weighs in on current investor sentiment in MedTech sector
-
BTIG Upgrades Globus Medical (GMED) to Buy
-
Globus Medical (GMED) PT Raised to $64 at Stifel
-
Globus Medical (GMED) PT Raised to $60 at Truist Securities
-
Globus Medical (GMED) Tops Q4 EPS by 2c; offers guidance
-
Globus Medical (GMED) promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
-
Globus Medical (GMED) PT Raised to $79 at Canaccord Genuity
-
Globus Medical (GMED) call put ratio 12.9 calls to 1 put as share price up 4.9%
-
Globus Medical (GMED) PT Raised to $58 at Truist Securities
-
Globus Medical (GMED) PT Raised to $71 at Canaccord Genuity
-
Globus Medical (GMED) PT Lowered to $70 at RBC Capital
-
Globus Medical (GMED) PT Lowered to $53 at Morgan Stanley
-
Globus Medical (GMED) PT Lowered to $53 at Truist Securities
-
Globus Medical (GMED) Tops Q3 EPS by 3c
-
Roth/MKM Starts Globus Medical (GMED) at Buy, 'concerns over sales force attrition are exaggerated'
-
Globus Medical (GMED) PT Lowered to $58 at Truist Securities
-
Stifel Upgrades Globus Medical (GMED) to Buy on discounted valuation
-
Globus Medical (GMED) PT Lowered to $58 at Wells Fargo
-
Goosehead Insurance (GSHD) and Jackson Financial (JXN) to Join S&P SmallCap 600
-
Globus Medical (GMED) PT Lowered to $65 at Truist Securities
-
Globus Medical (GMED) PT Raised to $63 at Wells Fargo
-
Globus Medical (GMED) Tops Q2 EPS by 4c, beats revenue
-
Globus Medical (GMED) PT Raised to $68 at Truist Securities
-
Globus Medical (GMED) PT Lowered to $60 at Morgan Stanley
-
Globus Medical (GMED) Announces FDA Approval for its Non-Fusion Scoliosis Correction System
-
Globus Medical (GMED) PT Lowered to $64 at Truist Securities
-
Globus Medical (GMED) Tops Q1 EPS by 2c
-
Globus Medical (GMED) Shareholders Approve Share Issuance for Merger with NuVasive (NUVA)
-
NuVasive (NUVA) Shareholders Approve Merger Agreement with Globus Medical (GMED)
-
Glass Lewis Recommends NuVasive (NUVA) Shareholders Vote "FOR" the Proposed Merger with Globus Medical (GMED)
-
NuVasive (NUVA) Announces ISS Recommends Shareholders Vote "FOR" the Proposed Merger with Globus Medical (GMED)
-
Globus Medical (GMED) re-filed the HSR Filing related to its NuVasive (NUVA) merger
-
Canaccord Genuity Upgrades Globus Medical (GMED) to Buy
-
Globus Medical (GMED) PT Lowered to $75 at Barclays
-
Globus Medical (GMED) PT Lowered to $64 at Morgan Stanley
-
Globus Medical (GMED) PT Lowered to $67 at Canaccord Genuity
-
Globus Medical (GMED) PT Lowered to $61 at Wells Fargo
-
Globus Medical (GMED) Tops Q4 EPS by 3c
-
Globus Medical (GMED) PT Lowered to $65 at Piper Sandler
-
BofA Securities Downgrades Globus Medical (GMED) to Underperform
-
Loop Capital Downgrades Globus Medical (GMED) to Hold
-
Needham & Company Downgrades Globus Medical (GMED) to Hold
-
Wells Fargo Downgrades Globus Medical (GMED) to Equal Weight
-
Truist Securities Downgrades Globus Medical (GMED) to Hold
-
BTIG Downgrades Globus Medical (GMED) to Neutral
-
Canaccord Genuity Downgrades Globus Medical (GMED) to Hold
-
CFRA Upgrades Globus Medical (GMED) to Hold
-
Piper Sandler Downgrades Globus Medical (GMED) to Neutral
-
Globus Medical (GMED) and NuVasive (NUVA) announce merger agreement
-
Globus Medical (GMED) and NuVasive (NUVA) to Combine in All-Stock Transaction
Back to GMED Stock Lookup